Logo-brb

Biomedical Research Bulletin

Biomed Res Bull. 2023;1(2): 53-59.
doi: 10.34172/biomedrb.2023.11
  Abstract View: 980
  PDF Download: 1125
  Full Text View: 745

Original Article

Down-regulation of Toll-like Receptor 2 Via HMGB1 Blocking With Kaempferol on Kupffer Cells From Hepatocellular Carcinoma Patients

Zhang Yue 1 ORCID logo, Tian Ma 2, Xu Zhang 1, Tong Ma 2* ORCID logo

1 Department of Immunology, Faculty of Medicine, Jiangsu University, Zhenjiang, China
2 Department of Surgery, First Affiliated Hospital of Suzhou University, Suzhou, China
*Corresponding Author: Tong Ma, Email: Tongma2022@yeah.net

Abstract

Background: Kaempferol is a pharmacological kaempferol that can inhibit many inflammatory factors implicated in cancer.

Methods: The present study focused on kaempferol function on the immunity signaling pathway. In this study, Kupffer cells were also isolated with new methods.

Results: Our results indicated that the levels of interleukin 17 (IL-17), IL-33, and IL-6 in supernatants from cultured Kupffer cells from patients were increased after stimulation with high mobility group box-1 (HMGB1), but the levels of these cytokines decreased after using kaempferol to prevent inflammation.

Conclusion: The findings of this study imply that the reduction of the Toll-like receptor 2 (TLR2) pathway and T helper 17 cell polarization may be due to HMGB1 blocking with Kaempferol in hepatocellular carcinoma.

Keywords: Kaempferol, HMGB1, TLR2
First Name
Last Name
Email Address
Comments
Security code


Abstract View:

Your browser does not support the canvas element.

PDF Download:

Your browser does not support the canvas element.


Full Text View:

Your browser does not support the canvas element.